IQVIA’s real world data is fact based that the research industry requires.
IQVIA is beneficial as:
· It has the data for five hundred and thirty million plus anonymous patients.
· Covers almost all the diseases including very rare conditions.
· Helps with observational data collection for five hundred and sixty five programs, six hundred and forty seven thousand patients, and eighty nine thousand sites across hundred countries.
· It has a compass integrated delivery network with twenty one million historic patients and 8 million active patients.
· RWD is fifty plus markets.
· Ten types of data as EMR integrated and enriched data, oncology EMR and survey data, genomic alteration data, adjudicated and pre-adjudicated claims, customer data, mortality data, hospital data, longitudinal prescriptions, observational study data and pro and social media information.
· Rich clinical assets supporting company’s needs across market.
· Helps expands data options.
· It contains custom dataset for in-depth research.
· Having data linkage and integration expertise.
· Contain enriched approaches.
Proprietary RWD catalogue identifying twenty seven hundred plus data sources in various therapeutic areas as oncology, cardiovascular, endocrine, nutritional, metabolic, musculoskeletal and connective tissues, neurology and respiratory.